Market Cap 113.52B
Revenue (ttm) 11.02B
Net Income (ttm) -535.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 28.50
Profit Margin -4.86%
Debt to Equity Ratio 0.00
Volume 2,581,700
Avg Vol 1,842,388
Day's Range N/A - N/A
Shares Out 256.80M
Stochastic %K 60%
Beta 0.51
Analysts Strong Sell
Price Target $515.46

Latest News on VRTX

Vertex to Participate in Upcoming Investor Conferences

May 15, 2025, 4:05 PM EDT - 17 days ago

Vertex to Participate in Upcoming Investor Conferences


Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?

May 6, 2025, 4:28 PM EDT - 26 days ago

Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?


Vertex Reports First Quarter 2025 Financial Results

May 5, 2025, 4:01 PM EDT - 27 days ago

Vertex Reports First Quarter 2025 Financial Results


GreensKeeper Q1 2025 Portfolio Update

Apr 10, 2025, 8:55 AM EDT - 7 weeks ago

GreensKeeper Q1 2025 Portfolio Update

AXP CHKP ELV GOOG GOOGL ICE ICLR


Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Mar 28, 2025, 4:05 PM EDT - 2 months ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio


Final Trades: Vertex Pharma, Netflix and the IYF

Mar 27, 2025, 5:14 PM EDT - 2 months ago

Final Trades: Vertex Pharma, Netflix and the IYF

NFLX IYF


Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals

Mar 24, 2025, 1:19 PM EDT - 2 months ago

Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals


Top 3 Health Care Stocks That May Keep You Up At Night In Q1

Mar 11, 2025, 8:55 AM EDT - 2 months ago

Top 3 Health Care Stocks That May Keep You Up At Night In Q1

SNY TSVT


Vertex to Participate in Upcoming March Investor Conferences

Feb 18, 2025, 4:05 PM EST - 3 months ago

Vertex to Participate in Upcoming March Investor Conferences